BackSorrento Therapeutics Overview

Sorrento Therapeutics Profit Margin

Profitability ratio analysis for SRNE.

Quarterly Profit Margin

-633.69%
↑ 66.92% YoY

As of Jun 2023

Annual Profit Margin (TTM)

-831.18%
↑ 12.98% YoY

Trailing 12 months ending Jun 2023

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin